2021. High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report. Research, Society and Development. 10, 13 (Oct. 2021), e93101321104. DOI:https://doi.org/10.33448/rsd-v10i13.21104.